Novo’s Next-Generation Obesity Shot Falls Short of Lilly Rival
Novo Nordisk A/S’s next-generation obesity shot delivered less weight loss than Eli Lilly & Co.’s rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market.People treated…